Pharmaceutical companies are careful to introduce ‘Viagra for women’ in the domestic market

When it comes to introduction of ‘Addvi(flibanserine)’, a FDA-approved female hyposexuality treatment, domestic pharmaceutical companies have been careful, meaning that more verification in its effectiveness and marketability is needed.

Having the FDA approval as a chance, however, the product has attracted a lot of interests as ‘Viagra for women,’ raised as a topic of conversation.

According...